ALK

Allergy solutions for life

Take back control

More than 500 million people worldwide have allergies. Many of them suffer in silence because the way ahead is too confusing.

allergy_solutions_for_life

Watch the video

News

See all

Post date
08/12/2020

Six-month interim report (Q2) 2020

Read more
Post date
08/05/2020

Release date of six-month interim report (Q2) 2020 for ALK and audio cast

Read more
Post date
05/20/2020

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Read more
Post date
05/11/2020

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Read more
Post date
05/06/2020

Three-month interim report (Q1) 2020

Read more
Post date
04/28/2020

Release date of three-month interim report (Q1) 2020 for ALK and audio cast

Read more
Post date
04/20/2020

ALK announces Health Canada approval of ITULATEK SLIT-tablets for the treatment of tree pollen allergy

Read more
Post date
03/19/2020

Grant of share options and performance shares to members of the Board of Management and key employees

Read more
Post date
03/11/2020

Annual General Meeting in ALK-Abelló A/S held on 11 March 2020

Read more

COVID-19 and the management of respiratory allergy

Join our webinar to gain better understanding of how to provide optimal care and minimise risk to patients and carers alike, during the next phase of the COVID-19 pandemic. The webinar is intended for Healthcare Professionals.

Seasonal allergy symptoms can be confused with COVID-19

Therefore allergy symptoms should be kept under the best possible control. Watch Dr Glenis Scadding's expert advise in respect of seasonal allergies and COVID-19.

For further information visit EUFOREA

seasonal_allergic_rhinitis_in_relation_to_covid-19

ALK in brief

Allergy at a glance

Allergic rhinitis - popularly known as hay fever - is a widespread chronic disease. It is estimated to affect one in four persons in the industrialised world.

Our solutions

By collecting information and the latest and most trusted solutions together in one place, we want to make allergy surprisingly simple to manage.